Coya Therapeutics, Inc. (COYA)
Develops immune cell therapies to treat neurodegenerative and autoimmune diseases.
$4.00-0.06%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-34.3%
The outlook
COYA is trading near its 52-week lows, well below both its 50- and 200-day moving averages. Analyst sentiment is mixed, with an average price target implying significant upside, though current market data reflects a bearish lean. The stock sits at the lower end of its recent trading range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Price targetAvg target +280% vs current price
Analyst price target
~12-month · 7 analysts$15.21average target+280.4% vs now
Now $4.00
Low $12.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$93.8M
52-wk high
$7.75
52-wk low
$3.71
50-day avg
$4.91
200-day avg
$5.09
Trailing P/E
—